Psyence Biomedical Ltd.
$11.3
▲
5.1%
2026-04-21 08:46:00
www.psyencebiomed.com
NCM: PBM
Explore Psyence Biomedical Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$7.77 M
Current Price
$11.3
52W High / Low
$468.38 / $1.92
Stock P/E
30.05
Book Value
$39.62
Dividend Yield
—
ROCE
-54.49%
ROE
-74.29%
Face Value
—
EPS
$-389.98
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
12
Beta
0.31
Debt / Equity
—
Current Ratio
8.09
Quick Ratio
11.04
Forward P/E
—
Price / Sales
—
Enterprise Value
$-6.35 M
EV / EBITDA
1.53
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Silence Therapeutics plc | $7.93 | — | $349.74 M | — | -76.17% | -90.27% | $2.6 / $0.5 | $1.32 |
| 2. | Silo Pharma, Inc. | $0.67 | — | $8.38 M | — | -61.55% | -74.57% | $1.19 / $0.22 | $0.47 |
| 3. | Q32 Bio Inc. | $6.65 | 3.26 | $97.29 M | — | 33.52% | 1.25% | $8.04 / $1.34 | $3.27 |
| 4. | Madrigal Pharmaceuticals, Inc. | $535 | — | $12.26 B | — | -31.61% | -42.49% | $615 / $265 | $26.39 |
| 5. | Arcellx, Inc. | $115 | — | $6.73 B | — | -50.64% | -53.42% | $115.13 / $47.86 | $6.95 |
| 6. | Rocket Pharmaceuticals, Inc. | $3.86 | — | $421.21 M | — | -76.11% | -60.27% | $8.26 / $2.19 | $2.56 |
| 7. | MindWalk Holdings Corp. | $1.27 | — | $59.32 M | — | -34.42% | -58.82% | $3.25 / $0.4 | $0.23 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q3 2024 | |
|---|---|---|
| Sales | 0 M | 0 M |
| Operating Profit | -1.51 M | -1.16 M |
| Net Profit | -0.75 M | 0.14 M |
| EPS in Rs | -0.33 | 0.06 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -3.66 M | -44.23 M | -3.23 M | -1.86 M |
| Net Profit | 1.01 M | -51.16 M | -3.21 M | -1.86 M |
| EPS in Rs | 0.44 | -22.31 | -1.4 | -0.81 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 7.32 M | 1.13 M | 1.59 M | 1.83 M |
| Total Liabilities | 0.59 M | 12.1 M | 1.79 M | 0.13 M |
| Equity | 6.72 M | -10.97 M | -0.2 M | 1.7 M |
| Current Assets | 6.56 M | 1.13 M | 1.59 M | 1.83 M |
| Current Liabilities | 0.59 M | 12.1 M | 1.79 M | 0.13 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -3.73 M | -2.95 M | -1.59 M | -1.4 M |
| Investing CF | -0.02 M | -0.01 M | 0 M | -0.03 M |
| Financing CF | 9.15 M | 2.35 M | 1.17 M | -1.63 M |
| Free CF | -3.74 M | -2.95 M | -1.59 M | -1.4 M |
| Capex | -0.01 M | -0.01 M | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 101.98% | -1495.53% | -72.55% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-02-02 | 1:0.16 |
| 2026-01-20 | 1:0.16 |
| 2025-05-05 | 1:0.125 |
| 2024-11-26 | 1:0.0133333 |